Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation.
Limited quarterly history available
Profit Margin needs at least three reported quarters before a meaningful chart is shown.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
N/A
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 735 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Avalyn Pharma Inc. Common Stock
Market Cap
$1.14B
Net Profit Margin
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
Net Profit Margin
-12.40%
TTM Avg
-22.32%
3Y Avg
-24.80%
5Y Avg
-16.46%
Market Cap
$1.15B
Net Profit Margin
2.07%
TTM Avg
2.94%
3Y Avg
0.11%
5Y Avg
-9.38%
Market Cap
$1.13B
Net Profit Margin
-13.51%
TTM Avg
-5.33%
3Y Avg
-11.32%
5Y Avg
-12.84%
Market Cap
$1.15B
Net Profit Margin
-287.84%
TTM Avg
-208.97%
3Y Avg
-281.06%
5Y Avg
-321.48%
Market Cap
$1.13B
Net Profit Margin
10.76%
TTM Avg
17.71%
3Y Avg
18.77%
5Y Avg
14.94%
Market Cap
$1.17B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.10B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.09B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalyn Pharma Inc. Common Stock (AVLN) | $1.14B | 0.00% | N/A | N/A | N/A |
| OPKO Health, Inc. (OPK)vs › | $1.13B | -12.40% | -22.32% | -24.80% | -16.46% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 2.07% | 2.94% | 0.11% | -9.38% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | -13.51% | -5.33% | -11.32% | -12.84% |
| Nektar Therapeutics (NKTR)vs › | $1.15B | -287.84% | -208.97% | -281.06% | -321.48% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 10.76% | 17.71% | 18.77% | 14.94% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | 0.00% | 0.00% | 0.00% | 0.00% |
| Replimune Group, Inc. (REPL)vs › | $1.10B | 0.00% | 0.00% | 0.00% | 0.00% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | 0.00% | 0.00% | 0.00% | 0.00% |
| IRadimed Corporation (IRMD)vs › | $1.08B | 26.70% | 26.54% | 25.84% | 21.67% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
